-

MedAvail Announces Continued Expansion of Its Technology Agreement With a North Texas Health System

Innovative self-serve pharmacy kiosks now embedded in 16 sites through technology agreement

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, today announced that a health system in North Texas has expanded its technology agreement with MedAvail, and has deployed MedAvail’s MedCenter technology at 16 emergency and urgent care sites in Texas.

Patients visiting these urgent and emergency care sites are able to consult virtually with a system pharmacist and fill their prescriptions at the point of care through the MedCenter, eliminating the need to make a separate trip to a pharmacy. Through MedAvail’s Pharmacy Technology segment, the company is able to enhance pharmacy services offered by healthcare providers and retail chains. Enterprise customers can purchase MedAvail’s technology in order to provide these solutions under their own brands.

“We are proud to offer our software and MedCenter technology to large healthcare systems focused on medication adherence and patient satisfaction,” said Dave Rawlins, Chief Commercial Officer at MedAvail. “Quick and convenient access to care is even more critical now than ever. MedAvail’s innovative pharmacy technology is adaptable to a number of different environments, enabling our partners to improve ease of medication access without compromising safety.”

About MedAvail

MedAvail (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

SOURCE MedAvail Holdings, Inc.

Contacts

Investor Relations
Caroline Paul
Gilmartin Group
ir@medavail.com

MedAvail Holdings Inc.

NASDAQ:MDVL

Release Versions

Contacts

Investor Relations
Caroline Paul
Gilmartin Group
ir@medavail.com

More News From MedAvail Holdings Inc.

MedAvail To Report 2022 Third Quarter Financial Results on November 10, 2022

MISSISSAUGA, Ontario & PHOENIX, Ariz.--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced it will report financial results for the third quarter of 2022 on Thursday, November 10, 2022, after market close. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. The conference call can be accessed by registering online for the live audio webcast on...

MedAvail Announces Technology Partnership with Progressive Care, Inc

MIAMI & MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-based retail pharmacy company, and Progressive Care Inc. (OTCQB: RXMD) ("Progressive Care”) a personalized healthcare services and technology company, are excited to announce a technology agreement to deploy five MedAvail MedCenters in Florida. MedAvail MedCenter’s unique medication dispensing technology will allow PharmcoRx, a subsidiary of Progressive Care, to provide phar...

MedAvail to Present at the H.C. Wainwright 24th Annual Global Investment Conference

MISSISSAUGA, Ontario & PHOENIX, Ariz.--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled retail pharmacy company, today announced that the company will be participating in the upcoming hybrid H.C. Wainwright 24th Annual Global Investment Conference in New York. MedAvail’s management is scheduled to present on Tuesday, September 13, 2022, at 2:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Invest...
Back to Newsroom